AngioDynamics to Present at Canaccord Adams 28th Annual Global Growth ConferenceQUEENSBURY, N.Y.--(BUSINESS WIRE)--Aug. 5, 2008--AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical devices used by interventional radiologists, nephrologists and surgeons for the minimally invasive treatment of cancer and peripheral vascular disease, announced today that it will present at the Canaccord Adams 28th Annual Global Growth Conference in Boston, MA on Thursday, August 14, 2008. Eamonn Hobbs, President and CEO of AngioDynamics, will present a review of the Company's business strategy and historical financial results at 11:30 a.m. Eastern Time.

Attendance at the conference is by invitation only. Individuals can listen to the live and archived presentation on the Internet by visiting the investor relations portion of the Company's website at: www.angiodynamics.com.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, surgeons, and other physicians for the minimally invasive treatment of cancer and peripheral vascular disease. The Company's diverse product line includes market-leading radiofrequency ablation systems, vascular access products, angiographic products and accessories, dialysis products, angioplasty products, drainage products, thrombolytic products, embolization products, venous products and the new IRE platform technology. More information is available at www.angiodynamics.com.

CONTACT: AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or


EVC Group, Inc.
Doug Sherk, 415-896-6820 (Investor Relations)
Jenifer Kirtland, 415-896-6820 (Investor Relations)
jkirtland@evcgroup.com
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com



SOURCE: AngioDynamics, Inc.